학술논문

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Document Type
Article
Source
In: The Lancet Oncology. (The Lancet Oncology, August 2021, 22(8):1139-1150)
Subject
Language
English
ISSN
14745488
14702045